Morgan Stanley’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-4,600
| Closed | -$2K | – | 6889 |
|
|
2016
Q1 | $2K | Sell |
4,600
-81,356
| -95% | -$35.4K | ﹤0.01% | 6442 |
|
|
2015
Q4 | $58K | Sell |
85,956
-90,096
| -51% | -$60.8K | ﹤0.01% | 5655 |
|
|
2015
Q3 | $171K | Buy |
176,052
+11,964
| +7% | +$11.6K | ﹤0.01% | 5161 |
|
|
2015
Q2 | $197K | Buy |
164,088
+83,209
| +103% | +$99.9K | ﹤0.01% | 5243 |
|
|
2015
Q1 | $85K | Sell |
80,879
-36,709
| -31% | -$38.6K | ﹤0.01% | 5595 |
|
|
2014
Q4 | $128K | Sell |
117,588
-71,465
| -38% | -$77.8K | ﹤0.01% | 5445 |
|
|
2014
Q3 | $204K | Sell |
189,053
-86,579
| -31% | -$93.4K | ﹤0.01% | 5132 |
|
|
2014
Q2 | $287K | Sell |
275,632
-145,009
| -34% | -$151K | ﹤0.01% | 4962 |
|
|
2014
Q1 | $432K | Buy |
420,641
+81,336
| +24% | +$83.5K | ﹤0.01% | 4655 |
|
|
2013
Q4 | $394K | Sell |
339,305
-29,734
| -8% | -$34.5K | ﹤0.01% | 4622 |
|
|
2013
Q3 | $621K | Buy |
369,039
+37,892
| +11% | +$63.8K | ﹤0.01% | 4184 |
|
|
2013
Q2 | $663K | Buy |
+331,147
| New | +$663K | ﹤0.01% | 4056 |
|